PL408261A1 - Plaster containing an analgesic substances as an innovative form of application, soothing and treating pain - Google Patents

Plaster containing an analgesic substances as an innovative form of application, soothing and treating pain

Info

Publication number
PL408261A1
PL408261A1 PL408261A PL40826114A PL408261A1 PL 408261 A1 PL408261 A1 PL 408261A1 PL 408261 A PL408261 A PL 408261A PL 40826114 A PL40826114 A PL 40826114A PL 408261 A1 PL408261 A1 PL 408261A1
Authority
PL
Poland
Prior art keywords
application
substances
soothing
active substances
analgesic
Prior art date
Application number
PL408261A
Other languages
Polish (pl)
Inventor
Przemysław Paweł Taciak
Adam Aleksander Mazurek
Krzysztof P. Kubica
Original Assignee
Przemysław Paweł Taciak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Przemysław Paweł Taciak filed Critical Przemysław Paweł Taciak
Priority to PL408261A priority Critical patent/PL408261A1/en
Publication of PL408261A1 publication Critical patent/PL408261A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem wynalazku jest innowacyjna forma aplikacji substancji przeciwbólowych, w postaci plastrów zawierających jedną lub kilka substancji czynnych. Struktura plastra opiera się na możliwości magazynowania i kontrolowanego uwalniania substancji biologicznie czynnych. Substancje aktywne, w zależności od konstrukcji plastra, mogą podlegać modyfikowanemu uwalnianiu (np. przedłużonemu). Analizy wykazały również synergię działania w przypadku kilku produktów. Ponadto, dokonano analizy zastosowania, w innowacyjnej formie plastrów, połączeń substancji o działaniu przeciwbólowym i przeciwzapalnym z innymi substancjami biologicznie czynnymi, poprawiającymi ich właściwości terapeutyczne.The subject of the invention is an innovative form of application of analgesic substances in the form of patches containing one or several active substances. The structure of the patch is based on the possibility of storage and controlled release of biologically active substances. Active substances, depending on the patch structure, may be subject to modified release (e.g. prolonged). Analyzes also showed synergy of action for several products. In addition, an analysis of the use, in an innovative form of patches, of combinations of analgesic and anti-inflammatory substances with other biologically active substances improving their therapeutic properties was performed.

PL408261A 2014-05-19 2014-05-19 Plaster containing an analgesic substances as an innovative form of application, soothing and treating pain PL408261A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL408261A PL408261A1 (en) 2014-05-19 2014-05-19 Plaster containing an analgesic substances as an innovative form of application, soothing and treating pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL408261A PL408261A1 (en) 2014-05-19 2014-05-19 Plaster containing an analgesic substances as an innovative form of application, soothing and treating pain

Publications (1)

Publication Number Publication Date
PL408261A1 true PL408261A1 (en) 2015-11-23

Family

ID=54543841

Family Applications (1)

Application Number Title Priority Date Filing Date
PL408261A PL408261A1 (en) 2014-05-19 2014-05-19 Plaster containing an analgesic substances as an innovative form of application, soothing and treating pain

Country Status (1)

Country Link
PL (1) PL408261A1 (en)

Similar Documents

Publication Publication Date Title
CY1121997T1 (en) CRYSTAL FORMS OF 2-((4S)-6-(4-CHLOROPHENYL)-1-METHYL-4H-BENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-YL)ACETAMIDE
MX2020010412A (en) Inhibitors of bruton's tyrosine kinase.
CL2015001985A1 (en) Thiazolcarboxamides and pyridinecarboxamide compounds, pim kinase inhibitors.
CL2016001231A1 (en) Autotaxin Inhibitor Compounds
TW201613919A (en) Inhibitors of Bruton's tyrosine kinase
BR112015015891A8 (en) SOLID SOLUTION PHARMACEUTICAL COMPOSITION, AND, USE OF A PHARMACEUTICAL COMPOSITION
CL2015002897A1 (en) Bace1 inhibitors
EA201691032A1 (en) IZHOCHROMEN DERIVATIVES AS PHOSFOINOSYTID-3-KINAZ INHIBITORS
BR112017009798A8 (en) polymeric hgh prodrugs
CY1123366T1 (en) 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
PH12016501371A1 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
CY1122882T1 (en) 3-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
MX2017013047A (en) Treatment of pain.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
CO7151515A2 (en) Methods to treat gait and / or balance deficiency in patients with multiple sclerosis using an aminopyridine
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
CL2016001054A1 (en) Compounds for the treatment of diabetes and complications of diseases derived from it
PL408261A1 (en) Plaster containing an analgesic substances as an innovative form of application, soothing and treating pain
GB2569682B (en) Topical composition for use in the treatment of burns
PL408262A1 (en) Plaster containing an anti-swelling substances as an innovative form of application in treatment of bruises and injuries of motor organs
PH12016502107A1 (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
PL414045A1 (en) Plaster containing antifungal substances in the form of a plaster, acting topically in treatment of skin mycosis
PL414044A1 (en) Plaster containing bactericidal and/or bacteriostatic and/or viricidal and/or fungicidal substances used topically as an innovative form of application in treatment of body injuries
UA115417U (en) METHOD OF PREVENTION AND TREATMENT OF HYPOXIC CHANGES IN CARBOPERITONEUM